Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model
Authors
Keywords
E2F-1, CIK cell, Orthotopic rectal cancer
Journal
TUMOR BIOLOGY
Volume 35, Issue 2, Pages 1113-1122
Publisher
Springer Nature
Online
2013-09-13
DOI
10.1007/s13277-013-1149-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers
- (2013) I-K Choi et al. CANCER GENE THERAPY
- Low Rectal Cancer
- (2013) Eric Rullier et al. DISEASES OF THE COLON & RECTUM
- Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
- (2012) Runmei Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity
- (2012) N. Ning et al. CANCER RESEARCH
- Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma
- (2012) L. Liu et al. CLINICAL CANCER RESEARCH
- A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
- (2012) James M. Burke et al. JOURNAL OF UROLOGY
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
- (2012) Padma Sampath et al. MOLECULAR THERAPY
- Two Hundred Years of Cancer Research
- (2012) Vincent T. DeVita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model
- (2012) Zhi Yang et al. PLoS One
- E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma
- (2012) Marina Palaiologou et al. VIRCHOWS ARCHIV
- Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development
- (2011) S Lavilla-Alonso et al. CANCER GENE THERAPY
- Impact of tumor microenvironment on oncolytic viral therapy
- (2010) Jeffrey Wojton et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery
- (2010) Hui Li et al. CYTOTHERAPY
- Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
- (2010) C. Hontscha et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24
- (2009) Yu-mei Wu et al. ACTA PHARMACOLOGICA SINICA
- A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
- (2009) J J Rojas et al. GENE THERAPY
- Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect
- (2009) D Kolodkin-Gal et al. GENE THERAPY
- Oncolytic viruses: a novel form of immunotherapy
- (2008) Robin J Prestwich et al. Expert Review of Anticancer Therapy
- Novel Murine Model for Colon Cancer: Non-Operative Trans-Anal Rectal Injection
- (2008) Melissa Donigan et al. JOURNAL OF SURGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More